Epigenetic inactivation and tumor suppressor activity of HAI-2/SPINT2 in gastric cancer

被引：46
|
作者：
Dong, Wenjie
Chen, Xiaobing [2 ]
Xie, Jing [3 ]
Sun, Pinghu
Wu, Yunlin [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Gastroenterol, Shanghai 200025, Peoples R China
[2] Henan Tumor Hosp, Dept Med Oncol, Zhengzhou, Peoples R China
[3] Shanghai Jiao Tong Univ, Dept Pathol, Rui Jin Hosp, Shanghai 200025, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CANCER | 2010年 / 127卷 / 07期
关键词：
gastric cancer; methylation; HAI-2/SPINT2; HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; RENAL-CELL CARCINOMA; HUMAN BREAST-CANCER; C-MET; OVARIAN-CANCER; PROTEASE INHIBITOR; BIKUNIN HAI-2/PB; MOUSE MODEL; EXPRESSION;
D O I：
10.1002/ijc.25161
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Hepatocyte growth factor (HGF) activator inhibitor type 2 (HAI-2/SPINT2) encodes Kunitz-type protease inhibitor that regulates HGF activity. Inspection of the human HAI-2/SPINT2 locus uncovered a large and dense CpG island within the 5' region of this gene. Analysis of cultured human gastric tumor lines indicated that HAI-2/SPINT2 expression is either undetectable or in low abundance in several lines; however, enhanced gene expression was measured in cells cultured on the DNA demethylating agent 5-aza-2'-deoxycytidine. Bisulfite DNA sequencing confirmed the densely methylated HAI-2/SPINT2 promoter region. Forced expression of HAI-2/SPINT2 induced cell apoptosis, suppressed anchorage independent growth in vitro and tumor growth in vivo. We investigated HAI-2/SPINT2 aberrant methylation in patients with gastric cancer. The HAI-2/SPINT2 methylation was found preferentially in cancerous tissues (30 of 40, 75%) compared with nontumor tissues (no methylation was detected), indicating that this aberrant characteristic is common in gastric malignancies. In conclusion, epigenetic inactivation of HAI-2/SPINT2 is a common event contributing to gastric carcinogenesis and may be a potential biomarker for gastric cancer.
引用
收藏
页码：1526 / 1534
页数：9
相关论文
共 50 条
  • [31] Epigenetic Inactivation of the Potential Tumor Suppressor Gene FOXF1 in Breast Cancer
    Lo, Pang-Kuo
    Lee, Ji Shin
    Liang, Xiaohui
    Han, Liangfeng
    Mori, Tsuyoshi
    Fackler, Mary Jo
    Sadik, Helen
    Argani, Pedram
    Pandita, Tej K.
    Sukumar, Saraswati
    CANCER RESEARCH, 2010, 70 (14) : 6047 - 6058
  • [32] Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2): Emerging key players in epithelial integrity and cancer
    Kataoka, Hiroaki
    Kawaguchi, Makiko
    Fukushima, Tsuyoshi
    Shimomura, Takeshi
    PATHOLOGY INTERNATIONAL, 2018, 68 (03) : 145 - 158
  • [33] Tumor Suppressor Activity and Inactivation of Galanin Receptor Type 2 by Aberrant Promoter Methylation in Head and Neck Cancer
    Misawa, Yuki
    Misawa, Kiyoshi
    Kanazawa, Takeharu
    Uehara, Takayuki
    Endo, Shori
    Mochizuki, Daiki
    Yamatodani, Takashi
    Carey, Thomas E.
    Mineta, Hiroyuki
    CANCER, 2014, 120 (02) : 205 - 213
  • [34] CircLMTK2 acts as a novel tumor suppressor in gastric cancer
    He, Jian
    Chen, Jie
    Ma, Ben
    Jiang, Li
    Zhao, Guangfa
    BIOSCIENCE REPORTS, 2019, 39
  • [35] Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling
    Sara Vanessa Bernhard
    Katarzyna Seget-Trzensiok
    Christian Kuffer
    Dragomir B. Krastev
    Lisa-Marie Stautmeister
    Mirko Theis
    Kristina Keuper
    Jan-Eric Boekenkamp
    Maik Kschischo
    Frank Buchholz
    Zuzana Storchova
    Cellular Oncology, 2022, 45 : 103 - 119
  • [36] Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling
    Bernhard, Sara Vanessa
    Seget-Trzensiok, Katarzyna
    Kuffer, Christian
    Krastev, Dragomir B.
    Stautmeister, Lisa-Marie
    Theis, Mirko
    Keuper, Kristina
    Boekenkamp, Jan-Eric
    Kschischo, Maik
    Buchholz, Frank
    Storchova, Zuzana
    CELLULAR ONCOLOGY, 2022, 45 (01) : 103 - 119
  • [37] Telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancer
    Koscielny, S
    Dahse, R
    Beleites, E
    Fiedler, W
    4TH EUROPEAN CONGRESS OF OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, VOLS 1 AND 2, 2000, : 699 - 706
  • [38] Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer
    Otani, Koji
    Li, Xiaoxing
    Arakawa, Tetsuo
    Chan, Francis K. L.
    Yu, Jun
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2013, 13 (05) : 445 - 455
  • [39] Epigenetic alteration of CCDC67 and its tumor suppressor function in gastric cancer
    Park, Sung-Joon
    Jang, Hay-Ran
    Kim, Mirang
    Kim, Jeong-Hwan
    Kwon, Oh-Hyung
    Park, Jong-Lyul
    Noh, Seung-Moo
    Song, Kyu-Sang
    Kim, Seon-Young
    Kim, Yeul-Hong
    Kim, Yong Sung
    CARCINOGENESIS, 2012, 33 (08) : 1494 - 1501
  • [40] Role of the TFIZ2 protein, a potential tumor suppressor in gastric cancer
    Worrall, Claire
    May, Felicity
    CANCER RESEARCH, 2009, 69
12345